关注
Xin Li
Xin Li
在 osu.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy
S Guo, M Vieweger, K Zhang, H Yin, H Wang, X Li, S Li, S Hu, ...
Nature communications 11 (1), 1-11, 2020
1182020
Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine—Specific Cancer Targeting with Undetectable Toxicity
DW Binzel, X Li, N Burns, E Khan, WJ Lee, LC Chen, S Ellipilli, W Miles, ...
Chemical Reviews 121 (13), 7398-7467, 2021
572021
Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance
H Wang, S Ellipilli, WJ Lee, X Li, M Vieweger, YS Ho, P Guo
Journal of Controlled Release 330, 173-184, 2021
472021
The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development
X Li, AS Bhullar, DW Binzel, P Guo
Advanced Drug Delivery Reviews, 114316, 2022
222022
Self-assembly of four generations of RNA dendrimers for drug shielding with controllable layer-by-layer release
X Li, M Vieweger, P Guo
Nanoscale 12 (31), 16514-16525, 2020
92020
RNA 4WJ for spontaneous cancer-targeting, effective tumor-regression, metastasis suppression, fast renal excretion and undetectable toxicity
X Li, K Jin, TC Cheng, YC Liao, WJ Lee, AS Bhullar, LC Chen, ...
Biomaterials, 122432, 2023
5*2023
In Vitro and In Vivo Evaluation of the Pathology and Safety Aspects of Three- and Four-Way Junction RNA Nanoparticles
K Jin, YC Liao, TC Cheng, X Li, WJ Lee, F Pi, D Jasinski, LC Chen, ...
Molecular Pharmaceutics, 2024
32024
Posterior eye delivery of angiogenesis-inhibiting RNA nanoparticles via subconjunctival injection
C Zhong, Z Shi, DW Binzel, K Jin, X Li, P Guo, SK Li
International Journal of Pharmaceutics, 124151, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–8